UAE, Dubai: The Dubai Health Authority (DHA) is displaying its latest innovations and smart solutions during Arab Health 2020, which is taking place from January 27 – 30 at the Dubai World Trade Centre.
Arab Health visitors are welcome to visit the authority’s stand (#CC130) to learn about the latest health services adopted by the DHA.
His Excellency Humaid Al Qutami, Director General of the Dubai Health Authority stressed that the DHA constantly works towards adopting the latest technology and solutions to provide the people of Dubai with quality services that exceeds their expectations and achieve their satisfaction.
This year the innovative services on display include:
Doctor for Every citizen
The initiative was launched to fulfill the goals of Article Five of the Fifty Year Charter. It provides UAE citizens with 24/7 telehealth consultation for free for diabetes, allergies, hypertension and dermatological issues through the Doctor for Every Citizen initiative. To book a consultation, the patient can download the DHA app or the patient can call the DHA toll free number 800 342 and book an appointment.
Baraem
Baraem is a short questionnaire, which can be accessed through the DHA App, which consists of 20 questions designed by the primary healthcare sector, to assess the development of children from nine months to six years of age. The survey assesses the development of the child’s movement, language, problem solving and social communication at different age levels.
DubaiHealthBooking.com
DubaiHealthBooking.com is a single platform for booking medical appointments in government and private health facilities in Dubai. It can be accessed via website (www. DubaiHealthBooking.com) or the DubaiHealthBooking.com App. It aims to enable residents to experience easy, convenient and accessible care while booking health facilities in Dubai.
Dawa’ee
Dawa’ee is a free medication home delivery service in Dubai for patients that visit DHA hospitals and health facilities. Patients that have a valid prescription from a DHA health facility and are Emiratis or have a valid ENAYA or SAADA health insurance programme, are eligible for this service. They can log onto the DHA website www.dha.gov.ae and request for the home delivery service.
Track and Trace System
The Pharmaceutical Track and Trace System aims to monitor medication from when they are at manufacturing companies (in the UAE or abroad) until they reach the patient.
Track and Trace System helps combat potential counterfeit medication and ensures accuracy and credibility concerning insurance claims for dispensing medications. The system also contributes to improving the management of medication inventory in Dubai and helps avoid any medication shortage.
Sheryan
Sheryan Dubai Health Licensing System is a digital gateway for registering and licensing healthcare professionals and facilities in Dubai. The system will enable those in charge of health facilities, to identify, from their countries, the conditions and mechanism of obtaining healthcare licenses for facilities in Dubai and to apply for an electronic application for registration and licensing, make adjustments, get the approvals required to their requests, reviewing plans and feasibility study electronically.
DHA App
DHA App provides all DHA services of DHA under one smart application. Using this app, Dubai residents will be able to access DHA’s Smart Services i.e., Manage Appointments, Lab Results and Medications. Users can also check for Medical Fitness Application Status, Register and Volunteer for Blood Donation services, to name a few.
Arab Health aims to provide a platform that showcases the latest innovations in healthcare from state-of-the-art imaging equipment to the most cost-effective disposables; developments in surgery to advances in prosthetics.
-Ends-
For further information, please contact:
Kamakshi Gupta and Noor Nazzal
Communications Analysts- Media Dept.
Dubai Health Authority
klgupta@dha.gov.ae nnnazzal@dha.gov.ae
+9714 2197455
About the Dubai Health Authority:
The Dubai Health Authority (DHA) was created, in June 2007, by Law 13 issued by His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE, Ruler of Dubai, with an expanded vision to include strategic oversight for the complete health sector in Dubai and enhance private sector engagement.
Prior to the establishment of the DHA, the Department of Health and Medical Services, which was established in 1973, was the functioning authority that almost exclusively focused on health service delivery.
In May 2018, H.H Sheikh Mohammed, issued Law No. (6) of 2018 of the DHA. The new Law further enables the DHA to achieve its objectives including regulating medical services in Dubai, enhancing competiveness and transparency, improving medical services and products based on international best practices and achieving the sector’s objectives according to approved strategic plans.
H.H Sheikh Mohammed also issued Decree No. 17 of 2018 establishing subsidiaries of the DHA: the Dubai Healthcare Corporation and Dubai Health Insurance Corporation to further enhance healthcare services in Dubai and enable DHA to fulfil its responsibilities and obligations.
Three new strategic sectors were also added as part of the decree; they include Strategy and Corporate Development, Health Regulation, and Shared Support Services.
In addition to overseeing the health sector for the Emirate of Dubai, the DHA also focuses on providing services through DHA healthcare facilities including Latifa, Dubai, Rashid and Hatta Hospitals, its 12 primary healthcare centres, 17 medical fitness centres and its 6 specialty centres.
For more information, visit DHA’s website: www.dha.gov.ae
© Press Release 2020Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
